Discover a safer alternative for managing wisdom tooth pain. A study reveals that combining over-the-counter pain relievers ...

Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to ...

And this stickiness is more pronounced after they’ve seen images related to opioids. The findings, published Jan. 17 in JAMA Network Open, shed light on the neural mechanisms relevant to substance use ...

A new study led by a Georgia State University researcher finds that the opioid epidemic and rural homelessness are ...

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term use of conventional antidepressants, there is a need for novel rapid acting ...

Interview: Vivozons oral non-opioid painkiller in development, paving way for U.S. addiction solutions Interview with Vivozon ...